Shares of IMS Health Holdings Inc. (NYSE:IMS) were down 3.7% during mid-day trading on Wednesday . The stock traded as low as $27.72 and last traded at $28.03, with a volume of 708,162 shares changing hands. The stock had previously closed at $29.12.

Several analysts have issued reports on IMS shares. Zacks Investment Research cut IMS Health Holdings from a “hold” rating to a “sell” rating in a research report on Wednesday, April 6th. TheStreet raised IMS Health Holdings from a “hold” rating to a “buy” rating in a research report on Wednesday, July 20th. Wells Fargo & Co. cut IMS Health Holdings from an “outperform” rating to a “market perform” rating in a research report on Thursday, May 12th. Finally, Topeka Capital Markets increased their target price on IMS Health Holdings from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Wednesday, May 4th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. IMS Health Holdings currently has an average rating of “Buy” and a consensus target price of $31.22.

The company has a 50 day moving average price of $26.33 and a 200 day moving average price of $25.57. The stock has a market capitalization of $9.55 billion and a P/E ratio of 59.43.

IMS Health Holdings (NYSE:IMS) last announced its earnings results on Wednesday, July 27th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.03. The firm earned $802 million during the quarter, compared to analysts’ expectations of $796.93 million. The firm’s revenue for the quarter was up 112.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.37 EPS. Equities analysts forecast that IMS Health Holdings Inc. will post $1.60 earnings per share for the current year.

Other hedge funds have recently made changes to their positions in the company. Rhumbline Advisers raised its stake in shares of IMS Health Holdings by 3.1% in the fourth quarter. Rhumbline Advisers now owns 121,648 shares of the company’s stock worth $3,098,000 after buying an additional 3,620 shares during the last quarter. California Public Employees Retirement System raised its stake in IMS Health Holdings by 6.3% in the fourth quarter. California Public Employees Retirement System now owns 371,200 shares of the company’s stock worth $9,454,000 after buying an additional 21,900 shares in the last quarter. Mizuho Trust & Banking Co. Ltd. bought a new stake in IMS Health Holdings during the fourth quarter worth $5,781,000. Gulf International Bank UK Ltd bought a new stake in IMS Health Holdings during the fourth quarter worth $1,338,000. Finally, Morgan Stanley raised its stake in IMS Health Holdings by 23.6% in the fourth quarter. Morgan Stanley now owns 757,030 shares of the company’s stock worth $19,280,000 after buying an additional 144,364 shares in the last quarter.

IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.